Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Oral Oncol. 2015 Nov 14;52:97–103. doi: 10.1016/j.oraloncology.2015.10.016

Figure 1. Time to recurrence.

Figure 1

(A) by survival group (surviving <24 months vs. >=24 months); (B) by HPV tumor status; (C) in patients surviving less than 24 months by HPV tumor status; (D) in patients surviving longer than 24 months by HPV tumor status; (E) HPV-positive patients by survival group; (F) HPV-negative patients by survival group.